Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06096246

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

Conditions: Persistent Atrial Fibrillation, Cardiac Arrhythmia, Catheter Ablation

Sex: All

Ages: 18 Years – 85 Years

Healthy volunteers: No

Phase: NA

Enrollment: 208

Sponsor: Barts & The London NHS Trust

Location: Barts Heart Centre London

Summary

The main aim of the research is to investigate whether patients undergoing pulmonary vein isolation with catheter ablation for persistent atrial fibrillation (AF) will have lower rates of AF recurrence than those treated by DC cardioversion without an ablation procedure.

Eligibility Criteria

Inclusion Criteria: * Ability to give informed consent * Age 18-85 years * Persistent AF (atrial fibrillation lasting \> 7days) of total continuous duration \ 40 * Patients in Persistent AF who have had more than one previous cardioversion. * Established diagnosis of Hypertrophic cardiomyopathy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06096246). StuddyBuddy aggregates publicly available trial information.